Skip to content
Open access · OA via OpenAlex

Transcriptomic signatures in breast cancer

Jianjiang Fu, Stefanie S. Jeffrey

Molecular BioSystems · 2007 · ▲ 12 citations

Abstract

High throughput DNA microarray technology has been broadly applied to the study of breast cancer to classify molecular subtypes, to predict outcome, survival, response to treatment, and for the identification of novel therapeutic targets. Although results are promising, this technology will not have a full impact on routine clinical practice until there is further standardization of techniques and optimal clinical trial design. Due to substantial disease heterogeneity and the number of genes being analyzed, collaborative, multi-institutional studies are required to accrue enough patients for sufficient statistical power. Newer bioinformatic approaches are being developed to assist with the analysis of this important data.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1039/b618163e
Canonical
link ↗
Fetched
2026-10-15 MST

Cite this

APA
Fu, J., &amp; Jeffrey, S.S. (2007). Transcriptomic signatures in breast cancer. <em>Molecular BioSystems</em>. https://doi.org/10.1039/b618163e
Vancouver
Fu J, Jeffrey SS. Transcriptomic signatures in breast cancer. Molecular BioSystems. 2007. doi:10.1039/b618163e.
BibTeX
@article{jianjiang2007Transc, title = {Transcriptomic signatures in breast cancer}, author = {Jianjiang Fu and Stefanie S. Jeffrey}, journal = {Molecular BioSystems}, year = {2007}, doi = {10.1039/b618163e}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings